4.1 Article

A REGULATORY PERSPECTIVE ON ESSENTIAL CONSIDERATIONS IN DESIGN AND ANALYSIS OF SUBGROUPS WHEN CORRECTLY CLASSIFIED

Journal

JOURNAL OF BIOPHARMACEUTICAL STATISTICS
Volume 24, Issue 1, Pages 19-41

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/10543406.2013.856022

Keywords

Biomarker; Formation of subgroup; Interaction-to-overall effects ratio; Predictive of treatment effect; Subgroup-specific treatment effect hypothesis

Funding

  1. RSR funds provided by the Center for Drug Evaluation and Research of the U.S. Food and Drug Administration [05-02, 05-14]

Ask authors/readers for more resources

This regulatory research provides possible approaches for improvement to conventional subgroup analysis in a fixed design setting. The interaction-to-overall effects ratio is recommended in the planning stage for potential predictors whose prevalence is at most 50% and its observed ratio is recommended in the analysis stage for proper subgroup interpretation if sample size is only planned to target the overall effect size. We illustrate using regulatory examples and underscore the importance of striving for balance between safety and efficacy when considering a regulatory recommendation of a label restricted to a subgroup. A set of decision rules gives guidance for rigorous subgroup-specific conclusions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available